cell cycle (Cullgen/Astellas)

N/A

Report date: 2025/01/26 17:58:50
NME

Base Information

Drug Namecell cycle (Cullgen/Astellas)
Drug Alias Namecell cycle (a) program
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell cycle inhibitorsImmunomodulators
TargetsUpdating
Therapy Area/IndicationsLung NeoplasmsPancreatic NeoplasmsBreast Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCullgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesAstellas Pharma IncCullgen Inc
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsPancreatic NeoplasmsBreast Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A